| Revenues | | 1,005.54 | - | 1,316.68 | 1,308.88 |
| Gross Profit | | 75.35 | - | - | - |
| | 84.14 | - | 1,312.67 | 1,311.25 |
| Research and Development | | 17.60 | - | 17.31 | 18.09 |
| Depreciation and Amortization | | 1.68 | - | 1.71 | 1.59 |
| Operating Income/Loss | | -8.79 | - | 4.02 | -2.38 |
| Nonoperating Income/Loss | | 0.14 | - | 0.41 | 0.55 |
| Income/Loss From Equity Method Investments | | -0.13 | - | -0.20 | -0.21 |
| Income/Loss From Continuing Operations Before Tax | | -8.65 | - | 4.43 | -1.82 |
| Income Tax Expense/Benefit | | -3.55 | - | 0.93 | 0.47 |
| | -5.10 | - | 3.50 | -2.29 |
| Attributable To Parent | | -5.10 | - | 3.50 | -2.29 |
| Available To Common Stockholders, Basic | -2.69 | - | - | - | - |
| Basic Average Shares | | 162.02 | - | 157.10 | 156.09 |
| Diluted Average Shares | | 162.02 | - | 160.77 | 156.09 |
| Basic Earnings Per Share | | -0.03 | - | 0.02 | -0.01 |
| Diluted Earnings Per Share | | -0.03 | - | 0.02 | -0.01 |
| Common Stock Dividends | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
